Which item should be described to ensure proper handling, labeling, and traceability of the investigational product during the trial?

• A. The dosage form, packaging, and labeling
• B. The budget of the investigational product
• C. The supplier's corporate history
• D. The market launch plan

Answer: (A)

Proper management of an investigational product in a trial relies on clear information about how the product is handled, labeled, and traced. Describing the dosage form, packaging, and labeling does this most directly. The dosage form tells you what is being administered and how it should be given, packaging protects the product and conveys storage and handling requirements, and labeling provides essential details such as trial identifiers, batch/lot numbers, expiration dates, and instructions for use. Together, these elements ensure correct dispensing, administration, and full traceability from manufacture through to the participant, which is crucial for safety, accountability, and regulatory compliance. Budgets, supplier history, or market launch plans do not address these operational controls.